Russia to begin COVID-19 vaccine trials on 40,000 people in the last week of August.

The mass testing of the first potential COVID-19 vaccine by Russia will involve more than 40000 people at 45 medical centers.

The mass testing of the first potential COVID-19 vaccine by Russia will involve more than 40000 people at 45 medical centers.Russia’s first potential COVID-19 vaccine called Sputnik V will begin Phase III of its clinical trials in the last week of August, which had received approval for domestic regulation on August 11, 2020.

Russian Direct Investment Fund(RDIF) that finances the vaccine project stated that the clinical study of the efficacy and safety of the vaccine will involve more than 40000 people for vaccination.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.